OVERSEA CHINESE BANKING Corp Ltd Makes New $7.06 Million Investment in The Clorox Company $CLX

OVERSEA CHINESE BANKING Corp Ltd acquired a new position in shares of The Clorox Company (NYSE:CLX) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 73,976 shares of the company’s stock, valued at approximately $7,060,000. OVERSEA CHINESE BANKING Corp Ltd owned approximately 0.06% of Clorox at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of CLX. Haverford Trust Co increased its stake in shares of Clorox by 2.8% in the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after buying an additional 84 shares in the last quarter. Field & Main Bank lifted its position in Clorox by 3.3% during the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after buying an additional 100 shares in the last quarter. Golden State Wealth Management LLC grew its holdings in Clorox by 28.2% during the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock worth $46,000 after acquiring an additional 100 shares during the last quarter. Kestra Private Wealth Services LLC grew its holdings in Clorox by 1.8% during the 1st quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock worth $617,000 after acquiring an additional 104 shares during the last quarter. Finally, Johnson Financial Group Inc. increased its position in Clorox by 3.1% in the 3rd quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock valued at $451,000 after acquiring an additional 109 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 1.8%

CLX opened at $106.00 on Friday. The firm has a 50 day simple moving average of $98.77 and a 200 day simple moving average of $103.11. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $128.90. The company has a market cap of $12.82 billion, a price-to-earnings ratio of 21.99, a price-to-earnings-growth ratio of 3.23 and a beta of 0.54. The company has a debt-to-equity ratio of 15.80, a current ratio of 0.66 and a quick ratio of 0.38.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.02. The firm had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.91 billion. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The business’s revenue for the quarter was down 2.0% on a year-over-year basis. During the same period last year, the firm earned $2.87 earnings per share. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, sell-side analysts anticipate that The Clorox Company will post 5.8 earnings per share for the current year.

Clorox Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Wednesday, August 12th will be paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 4.7%. This is a boost from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date of this dividend is Wednesday, August 12th. Clorox’s payout ratio is presently 103.73%.

Analyst Ratings Changes

A number of brokerages have weighed in on CLX. Wells Fargo & Company boosted their target price on shares of Clorox from $95.00 to $102.00 and gave the stock an “equal weight” rating in a research note on Tuesday, August 4th. UBS Group increased their price target on shares of Clorox from $100.00 to $105.00 and gave the company a “neutral” rating in a research note on Tuesday, August 4th. Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a research report on Friday, July 10th. Citigroup upped their price objective on Clorox from $97.00 to $100.00 and gave the stock a “neutral” rating in a report on Tuesday, August 4th. Finally, Morgan Stanley decreased their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. Twelve analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the stock. According to data from MarketBeat.com, Clorox has an average rating of “Reduce” and an average price target of $102.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.